A playful game to see if it lowers anxiety in palliative care patients
Official title: SPAMLO-3.0 : Having Fun Shedding Light on Darkness
Run by Centre Hospitalier de Saint-Brieuc · NCT07070869 · Data updated 2026-11-12
A serious game called SPAMLO-3.0 is being tested to see if it helps reduce anxiety for people receiving palliative care, compared with standard care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 280 (estimated) |
| Sponsor | Centre Hospitalier de Saint-Brieuc Academic / other |
| Locations | 8 sites (Dinan and 7 other locations) |
| Status | Recruiting |
| Started | July 2027 |
| Main results expected | July 2027 |
| Study ends | July 2027 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT07070869 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults in palliative care with a life expectancy >1 month, without cognitive impairments, own a device with internet access, and consent to participate.
✕Probably not a fit
Patients who are not anxious or who cannot engage with digital games may not experience a benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study tests whether adding the SPAMLO-3.0 serious game to standard palliative care can reduce anxiety in patients with limited life expectancy. Participants are randomized 1:1 to either standard care alone or standard care plus playing the SPAMLO-3.0 game for up to seven days. Anxiety and secondary outcomes are measured on Day 15 and Day 30, with data collection at inclusion, Day 15, and Day 30. The trial aims to explore whether a playful, educational game can improve emotional well-being in palliative care settings.
Why it matters
Potential benefit: If successful, patients may experience lower anxiety and improved quality of life during palliative care.
How similar studies have gone: Previous work suggests that digital and educational interventions can reduce anxiety in palliative care, but results are variable and this exact game is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participant for whom no curative treatment is proposed, who is either discharged home or hospitalized in palliative care * Life expectancy presumed to be greater than one month * No cognitive impairments, according to the healthcare team's assessment * Participantt has given free and informed consent * Participant affiliated with a social security system * The participant owns a computer, tablet, or smartphone with an internet connection and agrees to participate in the serious game SPAMLO-3.0. Exclusion Criteria: * Participant who is demented, confused, or in a coma * Fatigability, according to the healthcare team's assessment * Visually or hearing impaired participant, according to the healthcare team's assessment * No inclusion of persons targeted by Articles L. 1121-5 to L. 1121-8 and L. 1122-1-2 of the Public Health Code (e.g., minors, legally protected adults, etc.)
Where it's running
-
Groupe Hospitalier Rance Emeraude, site René Plevin
Dinan, France Recruiting -
Centre Hospitalier de Guingamp
Guingamp, France Recruiting -
Centre Hospitalier de Lannion - Trestel
Lannion, France Recruiting -
Centre Hospitalier Centre Bretagne
Noyal-Pontivy, France Recruiting -
Centre Hopsitalier de Saint-Brieuc - Paimpol - Tréguier, site de Paimpol
Paimpol, France Recruiting -
Centre Hospitalier Universitaire de Rennes, site de la Tauvrais
Rennes, France Recruiting
Show 2 more locations
-
Centre Hospitalier de Saint-Brieuc - Paimpol - Tréguier, site de Saint-Brieuc
Saint-Brieuc, France Recruiting -
HAD du Pays Briochin - Fondation AUB Santé
Saint-Brieuc, France Recruiting
Study contacts
- Principal investigator: Stéphanie LOUICHE — Centre Hospitalier de Saint-Brieuc - Paimpol - Tréguier
- Study coordinator: Fanny BEGUIER
- Email: fanny.beguier@armorsante.bzh
- Phone: 0296018165
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Single-session intervention to change ambiguity aversion
This trial tests whether one brief intervention can change how adults with intolerance of uncertainty and anxiety make ambiguous decisions and how their brains respond.
-
Using intranasal midazolam to treat anxiety in palliative care patients
This study is testing whether a nasal spray of midazolam can help reduce anxiety in patients receiving palliative care.
-
Using LSD to help relieve distress in terminally ill patients
This study is testing if LSD can help reduce pain, anxiety, and depression in people who are terminally ill and improve their overall quality of life.
-
See if preoperative anxiety affects recovery after major digestive cancer surgery
This study tests whether anxiety before surgery is linked to more complications after major digestive cancer operations in French-speaking adults.
-
Prehospital end-of-life care: how professionals use a comfort care booklet in Strasbourg
This study tests how emergency crew members in Strasbourg use a comfort care booklet when caring for patients at end of life, and what they think about it.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.